The outcome of intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss

Yıl 2019, Cilt: 29 Sayı: 2, 79 - 85, 03.06.2019

Emel Tahir Kemal Keseroğlu Serap Er Bülent Öcal Ali Özdek İstemihan Akın Ömer Bayır Mehmet Hakan Korkmaz

Öz

Objectives: The aim of this study is to evaluate the outcomes of intratympanic steroid ITS treatment for idiopathic sudden sensorineural hearing loss SSNHL . Patients and Methods: Between January 2014 and November 2016, medical charts of a total of 63 patients 47 males, 16 females; mean age: 44.2±17.5 years; range, 18 to 77 years who were hospitalized due to SSNHL were retrospectively analyzed. The patients were divided into two groups as those who received standard treatment Group 1, n=32 and those who received ITS treatment as a salvage treatment Group 2, n=31 . Treatment modalities and the results of pure tone audiometry tests were recorded. Recovery was assessed according to the Furuhashi criteria. Results: There was no significant difference in the hearing recovery rates between Group 1 and Group 2. In the patients receiving standard treatment, the recovery rate was significant 78% , while it was only 35.4% in the patients receiving ITS treatment p=0.361 . Conclusion: Although recent guidelines strongly recommend ITS treatment, in our study, ITS, which was started on Day 5 of admission, was not found to be superior to standard systemic treatment.

Anahtar Kelimeler

Intratympanic injection, salvage treatment, sudden sensorineural hearing loss

Kaynakça

• Gülüstan F, Yazıcı ZM, Alakhras WME, Erdur O, Acipayam H, Kufeciler L, et al. Intratympanic steroid injection and hyperbaric oxygen therapy for the treatment of refractory sudden hearing loss. Braz J Otorhinolaryngol. 2016 Nov 22. pii: S1808- 8694(16)30232-4.
• Atay G, Kayahan B, Çınar BÇ, Saraç S, Sennaroğlu L. Prognostic Factors in Sudden Sensorineural Hearing Loss. Balkan Med J 2016;33:87-93.
• Coelho DH, Thacker LR, Hsu DW. Variability in the management of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2011;145:813-7.
• Piccirillo JF. Steroids for idiopathic sudden sensorineural hearing loss: some questions answered, others remain. JAMA 2011;305:2114-5.
• Hosokawa S, Sugiyama K, Takahashi G, Takebayashi S, Mineta H. Prognostic factors for idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy and intravenous steroids. J Laryngol Otol 2017;131:77-82.
• Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif 2011;15:91-105.
• Belhassen S, Saliba I. Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss. J Laryngol Otol 2014;128:1044-9.
• Jung da J, Park JH, Jang JH, Lee KY. The efficacy of combination therapy for idiopathic sudden sensorineural 2016;126:1871-6. loss. Laryngoscope
• Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2011;268:833-9.
• Furuhashi A, Matsuda K, Asahi K, Nakashima T. Sudden deafness: long-term follow-up and recurrence. Clin Otolaryngol Allied Sci 2002;27:458-63.
• Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006;134:940-5.
• Narozny W, Kuczkowski J, Kot J, Stankiewicz C, Sicko Z, Mikaszewski B. Prognostic factors in sudden sensorineural hearing loss: our experience and a review of the literature. Ann Otol Rhinol Laryngol 2006;115:553-8.
• Naiboğllu B, Külekçi S, Sürmeli M, Verim A, Kalaycik Ertugay Ç, İhvan Ö, et al. Efficacy of multimodality approach to sudden hearing loss. Kulak Burun Bogaz Ihtis Derg 2015;25:77-81.
• Li P, Zeng XL, Ye J, Yang QT, Zhang GH, Li Y. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol Neurootol 2011;16:198-202.
• Swachia K, Sharma D, Singh J. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss. J Basic Clin Physiol Pharmacol 2016;27:371-7.
• Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. American Academy of Otolaryngology-Head and Neck Surgery. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(3 Suppl):S1-35.
• Qiang Q, Wu X, Yang T, Yang C, Sun H. A comparison between systemic and intratympanic steroid therapies as initial therapy for idiopathic sudden sensorineural hearing loss: a meta-analysis. Acta Otolaryngol 2017;137:598-605.
• Hong SM, Ko YG, Park CH, Lee JH, Kim JH. Analysis of hearing improvement in patients with severe to profound sudden sensorineural hearing loss according to the level of pure tone hearing threshold.Eur Arch Otorhinolaryngol 2012;269:2057-60.
• Jung SY, Shim HS, Hah YM, Kim SH, Yeo SG. Association of Metabolic Syndrome With Sudden Sensorineural Hearing Loss. JAMA Otolaryngol Head Neck Surg 2018;144:308-14.
• Yang HC, Cho YB, Jang CH, Cho HH. Efficacy of concomitant intratympanic steroid injection for sudden deafness according to initial hearing loss. Otol Neurotol 2015;36:1604-9.
• Topf MC, Hsu DW, Adams DR, Zhan T, Pelosi S, Willcox TO, et al. Rate of tympanic membrane perforation after intratympanic steroid injection. Am J Otolaryngol 2017;38:21-5.